【Detection principle】 This product uses fluorescent immunochromatographic method to quantitatively detect the FeLV/FIV content in the Serum/plasma of cats. Basic principle: T and C lines are marked on the nitrocellulose membrane, and the T line is coated with an antibody A that specifically recognizes the FeLV/FIV antigen. The binding pad is sprayed with another fluorescent nanomaterial-labeled antibody B capable of specifically recognizing FeLV/FIV. TheFeLV/FIV in the sample is first combined with the nanomaterial-labeled antibody B to form a complex, and then chromatographically upwards, the complex and T-line antibody A Combined to form a sandwich structure, when the excitation light is irradiated, the nanomaterial emits a fluorescent signal, and the strength of the signal is positively related to theFeLV/FIV concentration in the sample.
【Detection purpose】 Feline leukemia virus (FeLV) is a retrovirus that is widespread among felines worldwide.After cats are infected with the virus, the risk of developing tumors, such as lymphoma, is greatly increased; it can cause abnormal coagulation function or other blood diseases, such as regenerative/non-regenerative anemia; it can also cause the immune system to collapse, causing hemolytic anemia , glomerulonephritis and other diseases. Feline Immunodeficiency Virus is a disease caused feline AIDS. It is related to the HIV virus that causes AIDS in humans in terms of structure and nucleotide sequence. It also often produces clinical symptoms of immunodeficiency similar to that caused by human AIDS, but HIV in cats is not transmitted to humans. Therefore, reliable and effective detection has a positive guiding role in prevention and diagnosis and treatment.
